Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
HOSAN: Estrogen-progestin Combination in Anorexia Nervosa
NCT03172533Phase 2Terminated
- Sponsor
- FAU Erlangen-Nürnberg Medical Faculty
- Start
- Mar 2016
- Primary completion
- Jan 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of ethinyl estradiol and dienogest in anorexia nervosa (AN) (2 arms), sponsored by FAU Erlangen-Nürnberg Medical Faculty. Primary endpoint: Changes in neurocognitive performance at 10 weeks. Started Mar 2016; status: terminated.
02
Drugs
ethinyl estradioldienogest
03
Conditions
anorexia nervosa (AN)
Beyond the preview
Go deeper on NCT03172533.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03172533.